School of Medicine


Showing 21-40 of 120 Results

  • John Scandling

    John Scandling

    Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation

  • Lidia Schapira

    Lidia Schapira

    Professor of Medicine (Oncology)

    BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and served as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology from 2013 until 2023.

  • Erika Schillinger

    Erika Schillinger

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsMy passion is clinical skills education: the patient's experience of health and healthcare, doctor-patient communication, professionalism and physical exam. I am focused on curriculum design and innovation, having helped develop the Continuity of Care Clerkship, the clinical skills curriculum in Practice of Medicine, the Family Medicine core clerkship, outpatient faculty development modules and the SHIELD course (Stanford Healthcare Innovations and Experiential Learning Directive).

  • Ingela Schnittger, MD

    Ingela Schnittger, MD

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly InterestsMy main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.

  • Gary Schoolnik

    Gary Schoolnik

    Professor of Medicine (Infectious Diseases), Emeritus

    Current Research and Scholarly InterestsStructure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses

  • John S. Schroeder, MD

    John S. Schroeder, MD

    Professor (Clinical) of Medicine (Cardiovascular), Emeritus

    Current Research and Scholarly Interests1. Clinical Pharmocology of Cardiovascular Drugs
    (a) Calcium Channel Blockers
    (b) Agents for Heart Failure
    (c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers

    2. Cardiac Transplantation/Congestive Heart Failure

    3. Coronary Artery Spasm

  • Joseph Schroers-Martin

    Joseph Schroers-Martin

    Assistant Professor of Medicine (Oncology)

    Current Research and Scholarly InterestsMedical heme/onc focused on molecular cancer diagnostics and novel biomarkers.

  • Kevin Schulman

    Kevin Schulman

    Professor of Medicine (Hospital Medicine), by courtesy, of Health Policy and of Operations, Information and Technology at the Graduate School of Business

    BioDr. Schulman is a Professor of Medicine, Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business. He is the Faculty Director of Stanford’s new applied master's degree program, the Master of Science in Clinical Informatics Management program.

    Dr. Schulman is a health economist/health services researcher working at the intersection of business, medicine and technology. With over 500 publications, he has had a broad impact on several areas of health policy (Scopus h-index=81). His research has appeared in the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is the editor-in-chief of Health Management, Policy and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Service Research (HSR).

    He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program.

  • Jake Scott

    Jake Scott

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Jake Scott is a board-certified infectious diseases specialist. He provides general infectious diseases care in the inpatient and outpatient settings and his special interests include COVID-19, coccidiomycosis, multidrug-resistant organisms, HIV, and HIV pre-exposure prophylaxis. He works with patients from diverse backgrounds to provide compassionate, high-quality care aligned with their needs.

    Dr. Scott was born and raised in the Bay Area and was inspired to pursue a career in medicine after working as an HIV test counselor in San Francisco. He studied literature and creative writing in college and values the narrative aspect of medicine and the importance of drawing out the story behind the diagnosis.

    One of Dr. Scott’s passions is teaching. He regularly works with Stanford residents and students and has lectured on various infectious disease-related topics, such as COVID-19, fever of unknown origin, and the dangers of antibiotic overuse, especially as it contributes to the rising threat of multidrug-resistant infections. He is also committed to expanding awareness of infectious diseases outside of the hospital and university through public presentations in the community and media interviews.
    He is the medical director of the Antimicrobial Stewardship Program at Stanford Health Care – ValleyCare in Pleasanton and is a member of the Infection Control Committee and the Stanford Vaccine Clinical Advisory Committee.

    In his spare time, Dr. Scott enjoys rock climbing, hiking, and spending time with his wife and two young children.

  • Katharine Sears Edwards

    Katharine Sears Edwards

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsPotential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.

    Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).

    Assessment and training in evidence-based psychological therapies.

  • Rebecca Seekamp, MD

    Rebecca Seekamp, MD

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsInterested in complementary/alternative medicine, international health, international adoption medicine and providing full spectrum health care.

  • Niraj Sehgal

    Niraj Sehgal

    Clinical Professor, Medicine

    Current Research and Scholarly InterestsQuality Improvement & Patient Safety, Teamwork & Communication, Leadership
    Development, Organizational Culture & Change

  • Deborah Sellmeyer

    Deborah Sellmeyer

    Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    BioDr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.

  • Robert W. Shafer

    Robert W. Shafer

    Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology

    Current Research and Scholarly InterestsMy group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.

  • Atulkumar T. Shah, MD

    Atulkumar T. Shah, MD

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Shah is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care’s Digestive Health program. He is a clinical associate professor of medicine in the division of Gastroenterology and Hepatology at Stanford University School of Medicine.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    After more than two decades of practice, Dr. Shah added training in liver transplant to expand his knowledge of liver disease and offer his patients a “one-stop” resource for truly comprehensive care.

    Dr. Shah is a member of the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy, and American Association for the Study of Liver Disease.

    Among Dr. Shah’s current research interests is the development of an algorithm assessing the impact of gastrointestinal disease management on readmission rates.

    Dr. Shah brings a personalized approach to working with patients and to teaching the next generation of physician scientists the classic skills of careful listening and patient examination. Throughout his career, he has emphasized the fundamental importance of balancing scientific expertise with empathy and compassion.

    As a volunteer with the non-profit organization Health Volunteers Overseas, Dr. Shah travels around the world to train physicians about liver disease management and treatment. He is director of the HVO site in Bangalore, India.

  • Mamta Madhav Shah, MD

    Mamta Madhav Shah, MD

    Clinical Assistant Professor, Medicine - Nephrology

    BioDr. Shah is a board-certified, fellowship-trained nephrologist and clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.

    She provides care for patients with a variety of kidney-related conditions, with a special interest in management of kidney stones and related conditions. Her goal is to collaborate with each patient to develop a personalized and comprehensive care plan. She has given several talks on kidney stones to trainees and peers. Dr. Shah previously served as medical director of one of the dialysis clinics at University of Connecticut Health Center and helped run the plasmapheresis treatments.

    Some of Dr. Shah’s recent research is focused on efforts to prevent filter failure when performing membrane-based therapeutic plasma exchange—a blood purification treatment for removing large molecular weight substances from plasma.

    Dr. Shah’s work has been published in the Journal of Onco-Nephrology, Therapeutic Apheresis and Dialysis, and Connecticut Medicine. She has presented to her peers at national and regional meetings of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians, Connecticut Chapter.

    Dr. Shah is a member of the American Society of Nephrology. She has a keen interest in education of trainees including medical students, residents and fellows; and served as core faculty of the Nephrology Fellowship at the University of Connecticut Health Center.

    She is fluent in Hindi and Gujarati. Outside of work she enjoys traveling and spending time with her husband and daughter.